Breztri (budesonide/glycopyrrolate/formoterol fumarate), meanwhile, has been approved since 2020 in the US as a maintenance treatment used to reduce exacerbations in people living with chronic obstructive pulmonary disease (COPD).Sales of Breztri were $677 million last year, a rise of 73%, although AZ does not yet break out Airsupra revenues individually, as it is still in the rollout phase.
https://pharmaphorum.com/news/smart-sensor-cleared-use-az-asthma-copd-inhalers
Ann: US FDA clearance of Hailie for AstraZeneca inhalers, page-63
Add ADR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.8¢ |
Change
0.001(5.88%) |
Mkt cap ! $13.14M | |||
| Open | High | Low | Value | Volume |
| 1.7¢ | 1.8¢ | 1.7¢ | $24.12K | 1.339M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15405 | 1.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.9¢ | 405000 | 3 |
View Market Depth
| Last trade - 15.02pm 30/05/2024 (20 minute delay) ? |
|
|||||
|
Last
1.8¢ |
Change
0.001 ( 5.88 %) |
||||
| Open | High | Low | Volume | ||
| 1.8¢ | 1.8¢ | 1.8¢ | 607952 | ||
| Last updated 13.59pm 30/05/2024 ? | |||||
| ADR (ASX) Chart |